# ROPIVACAINE HYDROCHLORIDE

NDC: 43066-015
Generic name: ropivacaine hydrochloride
Labeler / Manufacturer: Baxter Healthcare Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: EPIDURAL, INFILTRATION, PERINEURAL
Marketing started: 20200409

FDA application: ANDA212808

## Active ingredients

- ROPIVACAINE HYDROCHLORIDE: 2 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"43066-015"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=43066-015
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=781d4b7f-7556-4695-8d48-7772d7a0d8e9